Zhang W G, Zhang Z S
Department of Pharmacology, Hubei Medical University, Wuhan.
Yao Xue Xue Bao. 1994;29(2):145-8.
Paeonol 60 mg.kg-1 ip, was given to rats for 15 days. On the 16th day myocardial ischemia reperfusion injury was produced in the rat heart by occlusion of the left coronary artery and the release of the occlusion. The results showed that paeonol significantly improved myocardial SOD activity (5.8 +/- 0.6.mg-1 compared with reperfusion control 3.4 +/- 0.9, P < 0.01), reduced the MDA content (11.4 +/- 1.7 nmol.mg-1 versus 17 +/- 1.3, P < 0.01) and cardiac CPK release (1523 +/- 478.5 U.L-1 versus 2355 +/- 626.5, P < 0.01). The myocardial ultrastructure was also protected keeping them from the oxygen free radical damage. It appears that paeonol is an efficient protective agent against ischemia reperfusion damage in the rat heart.
将60毫克/千克的丹皮酚腹腔注射给大鼠,持续15天。在第16天,通过结扎左冠状动脉并随后松开结扎来制造大鼠心脏的心肌缺血再灌注损伤。结果显示,丹皮酚显著提高了心肌超氧化物歧化酶(SOD)活性(5.8±0.6毫克-1,再灌注对照组为3.4±0.9,P<0.01),降低了丙二醛(MDA)含量(11.4±1.7纳摩尔/毫克-1,而对照组为17±1.3,P<0.01)以及心肌肌酸磷酸激酶(CPK)释放量(1523±478.5单位/升-1,而对照组为2355±626.5,P<0.01)。心肌超微结构也得到了保护,使其免受氧自由基损伤。看来丹皮酚是大鼠心脏缺血再灌注损伤的一种有效保护剂。